UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Human monoclonal antibodies targeting nonoverlapping epitopes on insulin-like growth factor II as a novel type of candidate cancer therapeutics Journal article
Weizao Chen, Yang Feng, Qi Zhao, Zhongyu Zhu, Dimiter S. Dimitrov. Human monoclonal antibodies targeting nonoverlapping epitopes on insulin-like growth factor II as a novel type of candidate cancer therapeutics[J]. MOLECULAR CANCER THERAPEUTICS, 2012, 11(7), 1400-1410.
Authors:  Weizao Chen;  Yang Feng;  Qi Zhao;  Zhongyu Zhu;  Dimiter S. Dimitrov
Favorite | TC[WOS]:24 TC[Scopus]:27  IF:5.3/5.4 | Submit date:2019/01/23
Human monoclonal antibody fragments binding to insulin-like growth factors I and II with picomolar affinity Journal article
Zhao, Q., Feng, Y., Zhu, Z., Dimitrov, D.. Human monoclonal antibody fragments binding to insulin-like growth factors I and II with picomolar affinity[J]. Molecular cancer therapeutics, 2011, 1677-1685.
Authors:  Zhao, Q.;  Feng, Y.;  Zhu, Z.;  Dimitrov, D.
Favorite |   IF:5.3/5.4 | Submit date:2023/08/30
monoclonal antibody  IGF-I  IGF-II  
Human monoclonal antibodies to IGF1/2 with picomolar affinity Journal article
Qi Zhao, Yang Feng, Zhongyu Zhu, Dimiter S. Dimitrov. Human monoclonal antibodies to IGF1/2 with picomolar affinity[J]. MOLECULAR CANCER THERAPEUTICS, 2011, 10(9), 1677-1685.
Authors:  Qi Zhao;  Yang Feng;  Zhongyu Zhu;  Dimiter S. Dimitrov
Favorite | TC[WOS]:35 TC[Scopus]:36  IF:5.3/5.4 | Submit date:2019/01/23
Mab  Igf2  Picomolar Affinity  Phage Display  Yeast Display  Igf1  
Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non-small cell lung cancers Journal article
Doody J.F., Wang Y., Patel S.N., Joynes C., Sui P.L., Gerlak J., Rolser R.L., Li Y., Steiner P., Bassi R., Hicklin D.J., Hadari Y.R.. Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non-small cell lung cancers[J]. Molecular Cancer Therapeutics, 2007, 6(10), 2642-2651.
Authors:  Doody J.F.;  Wang Y.;  Patel S.N.;  Joynes C.;  Sui P.L.; et al.
Favorite | TC[WOS]:47 TC[Scopus]:52 | Submit date:2019/01/16